Xbrane Biopharma AB (XBRANE) — Financial Flexibility Index
Xbrane Biopharma AB (XBRANE) has a Financial Flexibility Index of -0.05x as of June 2026. Free cash flow of Skr-4.71 Million (operating CF Skr-4.82 Million minus capex Skr108.00K) represents 0% of total liabilities (Skr103.76 Million). Check XBRANE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xbrane Biopharma AB Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Xbrane Biopharma AB across 13 annual periods. For the full cash flow conversion analysis, see Xbrane Biopharma AB (XBRANE) cash flow conversion.
Annual Financial Flexibility Index for Xbrane Biopharma AB (2013–2025)
Year-by-year free cash flow to debt coverage for Xbrane Biopharma AB. Explore XBRANE operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | Skr-111.05 Million | Skr-250.69 Million | Skr110.97 Million | ▼ -678.5% |
| 2024 | -0.13x | Skr-81.48 Million | Skr-133.73 Million | Skr633.89 Million | ▲ +84.1% |
| 2023 | -0.81x | Skr-389.91 Million | Skr-406.68 Million | Skr482.17 Million | ▼ -60.5% |
| 2022 | -0.50x | Skr-133.79 Million | Skr-193.92 Million | Skr265.63 Million | ▲ +9.1% |
| 2021 | -0.55x | Skr-142.26 Million | Skr-219.61 Million | Skr256.69 Million | ▲ +51.3% |
| 2020 | -1.14x | Skr-234.55 Million | Skr-238.41 Million | Skr206.06 Million | ▼ -19.4% |
| 2019 | -0.95x | Skr-147.40 Million | Skr-148.59 Million | Skr154.62 Million | ▼ -435.1% |
| 2018 | 0.28x | Skr48.30 Million | Skr46.71 Million | Skr169.81 Million | ▲ +119.2% |
| 2017 | -1.49x | Skr-33.50 Million | Skr-36.85 Million | Skr22.55 Million | ▲ +41.3% |
| 2016 | -2.53x | Skr-27.34 Million | Skr-39.43 Million | Skr10.81 Million | ▼ -526.0% |
| 2015 | -0.40x | Skr-11.24 Million | Skr-12.39 Million | Skr27.82 Million | ▲ +93.6% |
| 2014 | -6.35x | Skr-2.48 Million | Skr-2.67 Million | Skr390.70K | ▼ -46.1% |
| 2013 | -4.35x | Skr-2.20 Million | Skr-2.20 Million | Skr505.44K | — |